← All stocks

Oric Pharmaceuticals, Inc.

ORIC Net selling
CIK 0001796280 #2271 in the set updated 17 Sep 2026
Bought (120 mo)
$12.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$40.61M
$3.57M on a plan · $2.32M straight out of an exercise
Sold at will
$34.72M
89 of 117 sales
Net
−$28.01M
−$22.12M against sales at will

By person

12 insiders · 136 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORDON CARL L
Director
$4.50M (1)
$15.17M (14)
−$10.67M
2,212,571
2.13%
$30.28M
ORBIMED ADVISORS LLC entity
Director
$4.50M (1)
$15.17M (14)
−$10.67M
2,212,571
2.13%
$30.28M
Chacko Jacob
PRESIDENT AND CEO
$3.01M (6)
$6.48M (35)
−$3.47M
581,711
0.5612%
$7.96M
+2,619%
Piscitelli Dominic
Chief Financial Officer
$321.62K (1)
$2.76M (17) scheduled
−$2.43M
69,828
0.0674%
$955.66K
+35.9%
Heyman Richard A.
Director
$524.42K (20)
−$524.42K
464,798
0.4484%
$6.36M
+17.0%
SCHELLER RICHARD H
Director
$275.81K (12)
−$275.81K
39,092
0.0377%
$535.01K
+56.4%
You Angie
Director
$262.90K (2)
+$262.90K
28,000
0.0270%
$383.21K
Multani Pratik S
Chief Medical Officer
$222.56K (4)
−$222.56K
68,149
0.0657%
$932.68K
+215.0%
Topspin Fund L.P. entity
10% owner
(1)
$0.00
2,144,320
2.07%
$29.35M
+94.9%
Svennilson Peter
Director
4,768,181
4.60%
$65.26M
+6,258%
COLUMN GROUP II, LP entity
10% owner
3,568,255
3.44%
$48.83M
Kunkel Lori Anne
Director
84,200
0.0812%
$1.15M
Insider
Date
Role
Action
Shares
Price
Amount
You Angie
23 Jun 2025
Director
Buy
1,403
$9.43
$13.23K
You Angie
20 Jun 2025
Director
Buy
26,597
$9.39
$249.67K
Chacko Jacob
13 May 2022
President and CEO
Buy
76,072
$2.82
$214.56K
Chacko Jacob
12 May 2022
President and CEO
Buy
69,354
$2.75
$190.47K
Chacko Jacob
11 May 2022
President and CEO
Buy
304,574
$2.90
$883.57K
Piscitelli Dominic
31 Mar 2022
Chief Financial Officer
Buy
60,000
$5.36
$321.62K
Chacko Jacob
25 Mar 2022
President and CEO
Buy
50,000
$4.54
$227.17K
Chacko Jacob
24 Mar 2022
President and CEO
Buy
42,873
$5.03
$215.66K
Chacko Jacob
23 Mar 2022
President and CEO
Buy
257,127
$4.98
$1.28M
GORDON CARL L
24 Apr 2020
Director
Buy indirect
281,250
$16.00
$4.50M
ORBIMED ADVISORS LLC
24 Apr 2020
Director
Buy indirect
281,250
$16.00
$4.50M

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 11
Sales at will 89
Transactions with no price 1
Shares from compensation/vesting 20,396,870
Sales filed before the plan box existed 76
History held since 27 Apr 2020